On May 31, 2023, the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) appointed David M. Urso to be President and Chief Executive Officer (“CEO”) of the Company, effective as of June 2, 2023
Mr. Urso was also elected as a member of the Board, effective as of June 8, 2023
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
David M. Urso was appointed as President and Chief Executive Officer at Lite Strategy, Inc..
Action
appointed
Role
President and Chief Executive Officer
Exact text from the filing
On May 31, 2023, the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) appointed David M. Urso to be President and Chief Executive Officer (“CEO”) of the Company, effective as of June 2, 2023
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.